On March 20, 2024, the US Food & Drug Administration (FDA) issued a proposed rule titled Drug Products or Categories of Drug Products that Present Demonstrable Difficulties for Compounding Under ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback